Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AnaSpec has reached a non-exclusive distribution deal with In Vitro covering a broad spectrum of AnaSpec products in Europe, the two companies and Eurogentec Group, AnaSpec's parent company, announced on Wednesday.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.